Gedeon Richter: Cariprazine shows effectiveness in the treatment of mental health disorders with combined substance use disorder
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk
for quantifying-visualizing symptom severity in patients with different psychiatric conditions.
Cariprazine is available in 67 countries globally, and the number of total patients treated from launch in Europe and US is around 1.700.000 (different indications).
Media-contact: Zsuzsa Beke, Head of PR, zs.beke@gedeonrichter.com
View original content:https://www.prnewswire.co.uk/news-releases/gedeon-richter-cariprazine-shows-effectiveness-in-the-treatment-of-mental-health-disorders-with-combined-substance-use-disorder-302423265.html
en | boerse | 67927652 |
